Literature DB >> 9267640

Relationship between cup-disc ratio and optic disc diameter: the Blue Mountains Eye Study.

P R Healey1, P Mitchell, W Smith, J J Wang.   

Abstract

PURPOSE: To determine the effects of optic disc size on vertical cup-disc ratio in subjects free of glaucoma and other optic nerve disease.
METHODS: Data were collected from 3654 people, 49 years of age of older, living in the Blue Mountains, west of Sydney (NSW, Australia). Examinations performed included subjective refraction and Zeiss colour stereo optic disc photographs. Eye and camera magnification effects were corrected.
RESULTS: Mean vertical disc diameter was 1.51 mm (95% confidence interval (CI) 1.504-1.516 mm) and the mean vertical cup-disc ratio was 0.43 (95% CI 0.425-0.435). Both parameters were distributed unimodally. The cup-disc ratio was strongly associated with disc diameter. Controlling for other variables, cup-disc ratio increased 0.270 (95% CI 0.250-0.290) per mm increase in disc diameter.
CONCLUSIONS: Vertical optic disc diameter and cup-disc ratio are distributed near normally in older Australians. Optic discs with larger vertical diameters have considerably greater vertical cup-disc ratios.

Entities:  

Mesh:

Year:  1997        PMID: 9267640     DOI: 10.1111/j.1442-9071.1997.tb01771.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  10 in total

1.  The effect of optic disc diameter on vertical cup to disc ratio percentiles in a population based cohort: the Blue Mountains Eye Study.

Authors:  J G Crowston; C R Hopley; P R Healey; A Lee; P Mitchell
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

2.  Biometry and spectral domain optical coherence tomography parameters in children with large cupping.

Authors:  Jong Jin Jung; Seung-Hee Baek; Ungsoo Samuel Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-25       Impact factor: 3.117

3.  Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.

Authors:  Sapna S Gangaputra; Michael M Altaweel; Qian Peng; David S Friedman; P Kumar Rao; C Stephen Foster; Rosa Y Kim; Susan B Reed; Sunil K Srivastava; Ira G Wong; John H Kempen
Journal:  Ocul Immunol Inflamm       Date:  2011-08       Impact factor: 3.070

4.  Optic disk size variability between African, Asian, white, Hispanic, and Filipino Americans using Heidelberg retinal tomography.

Authors:  Michael I Seider; Roland Y Lee; Dandan Wang; Melike Pekmezci; Travis C Porco; Shan C Lin
Journal:  J Glaucoma       Date:  2009 Oct-Nov       Impact factor: 2.503

5.  Vertical cup/disc ratio in relation to optic disc size: its value in the assessment of the glaucoma suspect.

Authors:  D F Garway-Heath; S T Ruben; A Viswanathan; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

Review 6.  Optic disk size and glaucoma.

Authors:  Esther M Hoffmann; Linda M Zangwill; Jonathan G Crowston; Robert N Weinreb
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.197

7.  Evaluation of subjects with a moderate cup to disc ratio using optical coherence tomography and Heidelberg retina tomograph 3: impact of the disc area.

Authors:  Fatih Ulas; Ümit Dogan; Abdulgani Kaymaz; Fatih Çelik; Serdal Çelebi
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

8.  Clinical measurement and categorization of optic disc in glaucoma patients.

Authors:  Harsha B Laxmana Rao; G C Sekhar; Ganesh J Babu; Rajul S Parikh
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

9.  Optic disc topography of normal Indian eyes: an assessment using optical coherence tomography.

Authors:  Shaun Dacosta; Sheena Bilal; Babu Rajendran; P Janakiraman
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

Review 10.  Ageing and ocular surface immunity.

Authors:  Alireza Mashaghi; Jiaxu Hong; Sunil K Chauhan; Reza Dana
Journal:  Br J Ophthalmol       Date:  2016-07-04       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.